Get started
Author

Srinivasa Rao Yarguntla

Observed names: Rao Y. Srinivasa, S. R. Yarraguntla, SRINIVASA RAO Y., Srinivas Rao Yarraguntla, Srinivasa Rao Y, Srinivasa Rao Y., Srinivasa Rao YARGUNTLA, Srinivasa Rao YARRAGUNTLA, Srinivasa Rao Yaraguntla, Srinivasa Rao Yarraguntla, Srinivasa Yarguntla, Srinivasa Rao Yarguntla, Y. Srinivasa Rao, YARRAGUNTLA SRINIVASA RAO, Yarraguntla Srinivasa Rao
ORCID: 0000-0002-8803-9668
Observed ORCID: 0000-0002-8803-9668
OpenAlex ID: A5092815924
Mucoadhesive Microspheres for Controlled Drug Delivery
2004 · Kora Pattabhi Rama Chowdary, Yarraguntla Srinivasa Rao · Biological and Pharmaceutical Bulletin · 202
PDF
Development and Validation of a Highly Sensitive LC‐MS/MS Method for Quantification of Mutagenic N ‐Nitroso Desmethyl Citalopram in Drug Formulations
2025 · Bhaskar Vallamkonda, Srinivasa Rao Yarguntla, et al. · Separation Science Plus · 20
Emulgel-Novel Trend in Topical Drug Delivery System - Review Article
2021 · Satya Lakshmi S, Divya R, et al. · Research Journal of Pharmacy and Technology · 20
Application of Box-Behnken Design for Formulation Parameters of Eslicarbazepine Tablets
2021 · Paravastu Venkata Kamala Kumari, S. R. Yarraguntla, et al. · Indian Journal of Pharmaceutical Sciences · 20
PDF
RP-HPLC Method for Determination of Azelnidipine and Telmisartan in Pharmaceutical Dosage Form
2023 · Manisha Panda, Vasudha Dadi, et al. · Research Journal of Pharmacy and Technology · 19
Quality by Design‐Assisted RP‐HPLC Method for Determination of Ritonavir and Darunavir in Pharmaceutical Formulation Using Central Composite Design
2024 · Bhagavan Rajesh Babu Koppisetty, Varaprasada Rao Kollabathula, et al. · Separation Science Plus · 13
QbD based RP-HPLC method for simultaneous determination of a emtricitabine, tenofovir diproxil fumarate and efavirenz in tablet dosage form-an application to stability indicating assay
2023 · Bhagavan Rajesh Babu Koppisetty, Hemant Kumar Tatapudi, et al. · Analytical Chemistry Letters · 11
Simultaneous Spectrophotometric Estimation of amlodipine besylate and Perindopril Erbumine in tablet Formulation
2019 · Mounica P Siridevi, Kumar T. Hemant, et al. · Research Journal of Pharmacy and Technology · 9
Identification and structural characterization of lactose adduct impurities in isosorbide dinitrate and hydralazine hydrochloride tablets by liquid chromatography‐mass spectrometry and nuclear magnetic resonance studies
2023 · Venkatarao Muppavarapu, Gangu Naidu Challa, et al. · Separation Science Plus · 8
PDF
Utility of Quality by Design approach in RP-HPLC method development for quantification of lamivudine and effavirenz in combination formulation
2023 · Bhagavan Rajesh Babu KOPPİSETTY, Prof. Y. Rajendra PRASAD, et al. · Ankara Universitesi Eczacilik Fakultesi Dergisi · 8
PDF
RP-HPLC Method for Quantification of Bilastine and Monteleukast Sodium in Pharmaceutical Dosage form
2023 · Mohammed Sameera Bhanu, Vasudha Dadi, et al. · Research Journal of Pharmacy and Technology · 8
Method Development and Validation for the Simultaneous Estimation of Cinitapride and Pantoprazole in Solid Dosage Forms By RP-HPLC
2013 · SURYADEVARA VIDYADHARA, YARRAGUNTLA SRINIVASA RAO, et al. · Oriental Journal Of Chemistry · 8
Phospholipid-Based Ultraflexible Nanovesicular Gel of Sertaconazole Nitrate for the Treatment of Skin Fungal Infections: Statistical Optimization, In Vitro and Preclinical Assessment
2025 · Malleswara Peram, Sachin Patil, et al. · Gels · 7
Development of a validated RP-HPLC assay method for quantitative separation of Teriflunomide and its process-related impurities in bulk drugs
2023 · Bhagavan Rajesh Babu Koppisetty, Rajendra Prasad Yejella, et al. · Journal of Applied Pharmaceutical Science · 7
Multiple Reaction Monitoring LC‐MS/MS Quantification of N‐Nitrosamine Drug Substance Related Impurities of Clonidine in Drug Substance and in Tablet Dosage Form
2025 · Bhaskar Vallamkonda, Srinivasa Rao Yarguntla, et al. · Biomedical Chromatography · 6
The Role of Business Strategy in Advancing Sustainability Goals: a Comprehensive Systematic and Bibliometric Analysis
2025 · Senthil Kumar Jaya Prakash, Ravi Aluvala, et al. · Circular Economy and Sustainability · 5
Design, characterization and optimization of Rosuvastatin calcium nanosponges loaded transdermal patch
2024 · Satyalakshmi S, Karthik D, et al. · Research Journal of Pharmacy and Technology · 5
Characteristics, properties, and analytical and bio‐analytical methods of enzalutamide: A review
2023 · Ramachandra Bondigalla, Gangu Naidu Challa, et al. · Separation Science Plus · 5
Signal detection in pharmacovigilance: Methods, tools, and workflows from case identification to adverse drug reaction database entry
2025 · Vinodkumar Mugada, Vidyadhara Suryadevara, et al. · Przeglad Epidemiologiczny · 4
PDF
A Comprehensive New Approach to Method Development and Validation of Encorafenib using UV Spectroscopy in Bulk and Pharmaceutical Formulation
2024 · Anusha Gandi, Pavan Kumar Dudi, et al. · Hacettepe University Journal of the Faculty of Pharmacy · 4
PDF
Analyzing Paxlovid: Examining Its Properties, Characteristics, and Analytical and Bio‐Analytical Methods–A Comprehensive Review
2024 · Anusha Gandi, Pavan Kumar Dudi, et al. · Separation Science Plus · 4
PDF
Development and validation of stability indicating ultra‐high‐performance liquid chromatographic method for assay and impurities of mexiletine hydrochloride and mexiletine hydrochloride capsules
2024 · Venkatarao Muppavarapu, Gangu Naidu Challa, et al. · Separation Science Plus · 4
PDF
Development and Optimization of Orodispersible Tablets of Fexofenadine Hydrochloride (FFH) by Box-Behnken Statistical Design (BBD)
2022 · P. V. Kamala Kumari, M. Sai Sri Vastav, et al. · International Journal of Drug Delivery Technology · 4
PDF
A quality by design assisted RP-HPLC method utilizing central composite design for the assay of eliglustat and its organic impurities in drug
2024 · Dadi Vasudha, Challa Gangu Naidu, et al. · Analytical Chemistry Letters · 3
Implementation of analytical quality by design (AQbD) in RP-HPLC method development for quantification of allopurinol in pure and commercial formulations
2026 · Malleswara Rao Peram, Ashish Kalungtkar, et al. · Current Pharmaceutical Analysis · 2
Works count: 45
Citation count: 423
H-index: 8
I10-index: 7
Year
Topic
Type